Leica Biosystems applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance of Digital Pathology
VISTA, CA–May 11, 2017 – The digital pathology industry just took another step forward,with the FDA clearance of a whole slide imaging (WSI) system (Philips Intelli Site™ Pathology Solution)for review of digital surgical pathology slides.Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA)on this positive outcome from their ongoing collaboration.
A founding member of the DPA, Leica Biosystems pioneered the field of Digital Pathology. It was the first company to market commercial digital pathology solutions. In the U.S., Leica Biosystems has clearance from the FDA for Aperio eIHC, an in vitro diagnostic solution to aid pathologists in the interpretation of ER, PR, and